{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:52:53Z","timestamp":1794383573861,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University of Phayao and the Thailand Science Research and Innovation Fund","award":["5031\/2567"],"award-info":[{"award-number":["5031\/2567"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05056-w","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T12:24:14Z","timestamp":1755260654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential of Cannabidiol (CBD) to overcome extensively drug-resistant Acinetobacter baumannii"],"prefix":"10.1186","volume":"25","author":[{"given":"Atchariya","family":"Yosboonruang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anong","family":"Kiddee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achiraya","family":"Siriphap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grissana","family":"Pook-In","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittakun","family":"Suwancharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acharaporn","family":"Duangjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratsada","family":"Praphasawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanthawan","family":"Reuk-ngam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriwan","family":"Nawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Rawangkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"5056_CR1","doi-asserted-by":"publisher","first-page":"103887","DOI":"10.1016\/j.micpath.2019.103887","volume":"139","author":"A Pormohammad","year":"2020","unstructured":"Pormohammad A, Mehdinejadiani K, Gholizadeh P, Nasiri MJ, Mohtavinejad N, Dadashi M, Karimaei S, Safari H, Azimi T. Global prevalence of colistin resistance in clinical isolates of acinetobacter baumannii: A systematic review and meta-analysis. Microb Pathog. 2020;139:103887.","journal-title":"Microb Pathog"},{"issue":"1","key":"5056_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12879-017-2932-5","volume":"18","author":"H Huang","year":"2018","unstructured":"Huang H, Chen B, Liu G, Ran J, Lian X, Huang X, Wang N, Huang Z. A multi-center study on the risk factors of infection caused by multi-drug resistant acinetobacter baumannii. BMC Infect Dis. 2018;18(1):11.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5056_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12879-020-05321-y","volume":"20","author":"J Shi","year":"2020","unstructured":"Shi J, Sun T, Cui Y, Wang C, Wang F, Zhou Y, Miao H, Shan Y, Zhang Y. Multidrug resistant and extensively drug resistant acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis. 2020;20(1):597.","journal-title":"BMC Infect Dis"},{"key":"5056_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhin.2023.11.002","volume":"143","author":"MR De Blasiis","year":"2024","unstructured":"De Blasiis MR, Sciurti A, Baccolini V, Isonne C, Ceparano M, Iera J, De Vito C, Marzuillo C, Villari P, Migliara G. Impact of antibiotic exposure on antibiotic-resistant\u2009<\u2009em\u2009>\u2009Acinetobacter baumannii\u2009isolation in intensive care unit patients: a systematic review and meta-analysis. J Hosp Infect. 2024;143:123\u201339.","journal-title":"J Hosp Infect"},{"issue":"4","key":"5056_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ejcdt.2017.01.003","volume":"66","author":"AE Sileem","year":"2017","unstructured":"Sileem AE, Said AM, Meleha MS. Acinetobacter baumannii in ICU patients: A prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality. Egypt J Chest Dis Tuberculosis. 2017;66(4):693\u20138.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"issue":"3","key":"5056_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0037-1599225","volume":"38","author":"JP Lynch 3rd","year":"2017","unstructured":"Lynch JP 3rd, Zhanel GG, Clark NM. Infections due to acinetobacter baumannii in the ICU: treatment options. Semin Respir Crit Care Med. 2017;38(3):311\u201325.","journal-title":"Semin Respir Crit Care Med"},{"key":"5056_CR7","doi-asserted-by":"publisher","first-page":"e20200248","DOI":"10.1590\/0037-8682-0248-2020","volume":"53","author":"MNL Kurihara","year":"2020","unstructured":"Kurihara MNL, Sales RO, Silva KED, Maciel WG, Simionatto S. Multidrug-resistant acinetobacter baumannii outbreaks: a global problem in healthcare settings. Rev Soc Bras Med Trop. 2020;53:e20200248.","journal-title":"Rev Soc Bras Med Trop"},{"key":"5056_CR8","doi-asserted-by":"crossref","unstructured":"Mazzitelli M, Gregori D, Sasset L, Trevenzoli M, Scaglione V, Lo Menzo S, Marinello S, Mengato D, Venturini F, Tiberio I, et al. Cefiderocol-based versus colistin-based regimens for severe carbapenem-resistant Acinetobacter baumannii infections: a propensity score-weighted, retrospective cohort study during the first two years of the COVID-19 pandemic. Microorganisms. 2023;11(4):984.","DOI":"10.3390\/microorganisms11040984"},{"issue":"2","key":"5056_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3947\/ic.2024.0055","volume":"56","author":"SJ Choi","year":"2024","unstructured":"Choi SJ, Kim ES. Optimizing treatment for Carbapenem-Resistant acinetobacter baumannii complex infections: A review of current evidence. Infect Chemother. 2024;56(2):171\u201387.","journal-title":"Infect Chemother"},{"issue":"4","key":"5056_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/ijmr.ijmr_3470_21","volume":"158","author":"D Gautam","year":"2023","unstructured":"Gautam D, Dolma KG, Khandelwal B, Goyal RK, Mitsuwan W, Pereira MLG, Klangbud WK, Gupta M, Wilairatana P, Siyadatpanah A, et al. Acinetobacter baumannii in suspected bacterial infections: association between multidrug resistance, virulence genes, & biofilm production. Indian J Med Res. 2023;158(4):439\u201346.","journal-title":"Indian J Med Res"},{"issue":"11","key":"5056_CR11","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/jcpt.13787","volume":"47","author":"R Dehbanipour","year":"2022","unstructured":"Dehbanipour R, Ghalavand Z. Acinetobacter baumannii: pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on Tigecycline. J Clin Pharm Ther. 2022;47(11):1875\u201384.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"5056_CR12","doi-asserted-by":"publisher","first-page":"2289769","DOI":"10.1080\/21505594.2023.2289769","volume":"15","author":"M Lucidi","year":"2024","unstructured":"Lucidi M, Visaggio D, Migliaccio A, Capecchi G, Visca P, Imperi F, Zarrilli R. Pathogenicity and virulence of acinetobacter baumannii: factors contributing to the fitness in healthcare settings and the infected host. Virulence. 2024;15(1):2289769.","journal-title":"Virulence"},{"key":"5056_CR13","doi-asserted-by":"crossref","unstructured":"Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Acinetobacter baumannii Infection-Related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics. 2022;11(8):1086.","DOI":"10.3390\/antibiotics11081086"},{"key":"5056_CR14","doi-asserted-by":"crossref","unstructured":"Jesudason T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe. 2024;5(9):100940.","DOI":"10.1016\/j.lanmic.2024.07.003"},{"key":"5056_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2017.00422","volume":"8","author":"P Morales","year":"2017","unstructured":"Morales P, Reggio PH, Jagerovic N. An overview on medicinal chemistry of synthetic and natural derivatives of Cannabidiol. Front Pharmacol. 2017;8:422.","journal-title":"Front Pharmacol"},{"issue":"12","key":"5056_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanu\u0161","year":"2016","unstructured":"Hanu\u0161 LO, Meyer SM, Mu\u00f1oz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357\u201392.","journal-title":"Nat Prod Rep"},{"key":"5056_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpba.2017.11.073","volume":"150","author":"L Calvi","year":"2018","unstructured":"Calvi L, Pentimalli D, Panseri S, Giupponi L, Gelmini F, Beretta G, Vitali D, Bruno M, Zilio E, Pavlovic R, et al. Comprehensive quality evaluation of medical cannabis sativa L. inflorescence and macerated oils based on HS-SPME coupled to GC\u2013MS and LC-HRMS (q-exactive orbitrap\u00ae) approach. J Pharm Biomed Anal. 2018;150:208\u201319.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"5056_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/head.13345","volume":"58","author":"EP Baron","year":"2018","unstructured":"Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science. Headache: J Head Face Pain. 2018;58(7):1139\u201386.","journal-title":"Headache: J Head Face Pain"},{"key":"5056_CR19","doi-asserted-by":"crossref","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants. 2019;9(1):21.","DOI":"10.3390\/antiox9010021"},{"key":"5056_CR20","doi-asserted-by":"crossref","unstructured":"Coelho MJ, Ara\u00fajo MD, Carvalho M, Cardoso IL, Manso MC, Pina C. Antimicrobial potential of cannabinoids: a scoping review of the past 5 years. Microorganisms. 2025;13(2):325.","DOI":"10.3390\/microorganisms13020325"},{"issue":"1","key":"5056_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","volume":"4","author":"MAT Blaskovich","year":"2021","unstructured":"Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, et al. The antimicrobial potential of Cannabidiol. Commun Biology. 2021;4(1):7.","journal-title":"Commun Biology"},{"issue":"1","key":"5056_CR22","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1038\/s41598-022-10393-8","volume":"12","author":"N Abichabki","year":"2022","unstructured":"Abichabki N, Zacharias LV, Moreira NC, Bellissimo-Rodrigues F, Moreira FL, Benzi JRL, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, et al. Potential Cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Sci Rep. 2022;12(1):6454.","journal-title":"Sci Rep"},{"issue":"3","key":"5056_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsinfecdis.9b00419","volume":"6","author":"MA Farha","year":"2020","unstructured":"Farha MA, El-Halfawy OM, Gale RT, MacNair CR, Carfrae LA, Zhang X, Jentsch NG, Magolan J, Brown ED. Uncovering the hidden antibiotic potential of cannabis. ACS Infect Dis. 2020;6(3):338\u201346.","journal-title":"ACS Infect Dis"},{"issue":"2","key":"5056_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/can.2023.0124","volume":"9","author":"CB Martinena","year":"2024","unstructured":"Martinena CB, Corleto M, Mart\u00ednez MMB, Amiano NO, Garc\u00eda VE, Maffia PC, Tateosian NL. Antimicrobial effect of Cannabidiol on intracellular Mycobacterium tuberculosis. Cannabis Cannabinoid Res. 2024;9(2):464\u20139.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"5056_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12889-019-7127-0","volume":"19","author":"CE French","year":"2019","unstructured":"French CE, Coope CM, McGuinness LA, Beck CR, Newitt S, Ahyow L, Hickman M, Oliver I. Cannabis use and the risk of tuberculosis: a systematic review. BMC Public Health. 2019;19(1):1006.","journal-title":"BMC Public Health"},{"key":"5056_CR26","unstructured":"Atchariya Yosboonruang CJ, Lalitphan T. Incidence of resistant bacteria isolated from medical devices in the intensive care unit of a hospital. J Public Health. 2017;47(2)."},{"issue":"11","key":"5056_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1469-0691.2011.03696.x","volume":"18","author":"P Espinal","year":"2012","unstructured":"Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I. Rapid and accurate identification of genomic species from the acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect. 2012;18(11):1097\u2013103.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5056_CR28","doi-asserted-by":"publisher","first-page":"210.e211","DOI":"10.1016\/j.cmi.2016.11.020","volume":"23","author":"M Mar\u00ed-Almirall","year":"2017","unstructured":"Mar\u00ed-Almirall M, Cosgaya C, Higgins PG, Van Assche A, Telli M, Huys G, Lievens B, Seifert H, Dijkshoorn L, Roca I, et al. MALDI-TOF\/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species. Clin Microbiol Infect. 2017;23(3):210.e211-210.e219.","journal-title":"Clin Microbiol Infect."},{"key":"5056_CR29","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 30th Informational Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020."},{"key":"5056_CR30","doi-asserted-by":"crossref","unstructured":"Siriphap A, Kiddee A, Duangjai A, Yosboonruang A, Pook-In G, Saokaew S, Sutheinkul O, Rawangkan A: Antimicrobial Activity of the Green Tea Polyphenol (\u2212)-Epigallocatechin-3-Gallate(EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae. Antibiotics. 2022;11(4):518.","DOI":"10.3390\/antibiotics11040518"},{"key":"5056_CR31","doi-asserted-by":"publisher","first-page":"865684","DOI":"10.3389\/fnut.2022.865684","volume":"9","author":"A Rawangkan","year":"2022","unstructured":"Rawangkan A, Siriphap A, Yosboonruang A, Kiddee A, Pook-In G, Saokaew S, Sutheinkul O, Duangjai A. Potential antimicrobial properties of coffee beans and coffee By-Products against Drug-Resistant vibrio cholerae. Front Nutr. 2022;9:865684.","journal-title":"Front Nutr"},{"issue":"5","key":"5056_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/mdr.2012.0252","volume":"19","author":"S Chusri","year":"2013","unstructured":"Chusri S, Jittanon W, Maneenoon K, Voravuthikunchai SP. An effective antibiofilm agent against Pseudomonas aeruginosa biofilm from traditional Thai herbal recipes used for wound treatments. Microb Drug Resist. 2013;19(5):337\u201343.","journal-title":"Microb Drug Resist"},{"key":"5056_CR33","doi-asserted-by":"crossref","unstructured":"Kiddee A, Yosboonruang A, Siriphap A, Pook-In G, Suwancharoen C, Duangjai A, Praphasawat R, Suganuma M, Rawangkan A. Restoring multidrug-resistant escherichia coli sensitivity to ampicillin in combination with (\u2013)-Epigallocatechin gallate. Antibiotics. 2024;13(12):1211.","DOI":"10.3390\/antibiotics13121211"},{"issue":"4","key":"5056_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.14740\/wjon1602","volume":"14","author":"R Praphasawat","year":"2023","unstructured":"Praphasawat R, Thakaew S, Rawangkan A, Thongboontho R, Sooksaen P, Laovittayangkoon S, Klajing W, Jaengpromma P, Kunsorn P, Suwannalert P, et al. Anticancer and antimutagenic properties of pogonatherum paniceum on colorectal cancer cells. World J Oncol. 2023;14(4):266\u201376.","journal-title":"World J Oncol"},{"key":"5056_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","volume":"6","author":"N Singhal","year":"2015","unstructured":"Singhal N, Kumar M, Kanaujia PK, Virdi JS. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol. 2015;6:791.","journal-title":"Front Microbiol"},{"issue":"3","key":"5056_CR36","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.infpip.2020.100077","volume":"2","author":"SE Weinberg","year":"2020","unstructured":"Weinberg SE, Villedieu A, Bagdasarian N, Karah N, Teare L, Elamin WF. Control and management of multidrug resistant acinetobacter baumannii: A review of the evidence and proposal of novel approaches. Infect Prev Pract. 2020;2(3):100077.","journal-title":"Infect Prev Pract"},{"key":"5056_CR37","doi-asserted-by":"crossref","unstructured":"Harris AD, Johnson JK, Pineles L, O\u2019Hara LM, Bonomo RA, Thom KA. Patient-to-Patient transmission of acinetobacter baumannii Gastrointestinal colonization in the intensive care unit. Antimicrob Agents Chemother. 2019;63(8):e00392.","DOI":"10.1128\/AAC.00392-19"},{"key":"5056_CR38","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.2147\/IDR.S383285","volume":"15","author":"AL Golli","year":"2022","unstructured":"Golli AL, Cristea OM, Zlatian O, Glodeanu AD, Balasoiu AT, Ionescu M, Popa S. Prevalence of Multidrug-Resistant pathogens causing bloodstream infections in an intensive care unit. Infect Drug Resist. 2022;15:5981\u201392.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5056_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42269-023-00982-6","volume":"47","author":"AB Abed","year":"2023","unstructured":"Abed AB, Korcan SE, G\u00fcng\u00f6r S. Antibiotics profile map of clinical A. baumannii strains isolated from health institutions in turkey: a database search study and analysis of publications from 2011 to 2022. Bull Natl Res Centre. 2023;47(1):15.","journal-title":"Bull Natl Res Centre"},{"key":"5056_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jgar.2024.01.019","volume":"36","author":"S-C Hsueh","year":"2024","unstructured":"Hsueh S-C, Huang Y-T, Ko W-C, Liu IM, Hsieh P-C, Jean S-S. In vitro antimicrobial susceptibility data of global meropenem-resistant acinetobacter baumannii isolates causing pneumonia: data from the antimicrobial testing leadership and surveillance program, 2014\u20132021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment. J Global Antimicrob Resist. 2024;36:411\u20138.","journal-title":"J Global Antimicrob Resist"},{"key":"5056_CR41","doi-asserted-by":"crossref","unstructured":"Garz\u00f3n HS, Loaiza-Oliva M, Mart\u00ednez-Pab\u00f3n MC, Puerta-Su\u00e1rez J, T\u00e9llez Corral MA, Bueno-Silva B, Su\u00e1rez DR, D\u00edaz-B\u00e1ez D, Su\u00e1rez LJ. Antibiofilm and immune-modulatory activity of cannabidiol and cannabigerol in oral environments\u2014in vitro study. Antibiotics. 2024;13(4):342.","DOI":"10.3390\/antibiotics13040342"},{"key":"5056_CR42","doi-asserted-by":"publisher","first-page":"122188","DOI":"10.1016\/j.jchromb.2020.122188","volume":"1150","author":"AI Fraguas-S\u00e1nchez","year":"2020","unstructured":"Fraguas-S\u00e1nchez AI, Fern\u00e1ndez-Carballido A, Martin-Sabroso C, Torres-Su\u00e1rez AI. Stability characteristics of Cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1150:122188.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"5056_CR43","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.1021\/acsnano.2c12488","volume":"17","author":"J Butler","year":"2023","unstructured":"Butler J, Handy RD, Upton M, Besinis A. Review of antimicrobial nanocoatings in medicine and dentistry: mechanisms of action, biocompatibility performance, safety, and benefits compared to antibiotics. ACS Nano. 2023;17(8):7064\u201392.","journal-title":"ACS Nano"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05056-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05056-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05056-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T03:10:50Z","timestamp":1757387450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05056-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5056"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05056-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}